Home » EC Slaps Huge Fines on Lundbeck, Generics for Pay-for-Delay Deals
EC Slaps Huge Fines on Lundbeck, Generics for Pay-for-Delay Deals
July 10, 2013
The European Commission June 19 slapped Lundbeck with a nearly $126 million fine, and levied fines totaling $70 million on four of its generic rivals for their respective roles in 2002 pay-for-delay settlement deals tied to the Danish drugmaker’s antidepressant citalopram.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor